TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort-Reference-Cited by-同舟云学术

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort

Published:2019-01-03 Issue:2 Volume:18 Page:273-280
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Bakhuizen J. J.^ORCID,Hogervorst F. B.,Velthuizen M. E.,Ruijs M. W.,van Engelen K.,van Os T. A.,Gille J. J.,Collée M.,van den Ouweland A. M.,van Asperen C. J.,Kets C. M.,Mensenkamp A. R.,Leter E. M.,Blok M. J.,de Jong M. M.,Ausems M. G.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-018-00118-0.pdf

Reference54 articles.

1. Netherlands Comprehensive Cancer Organisation (IKNL) (2016) Dutch cancer Figs. 2016 [Internet]. http://www.cijfersoverkanker.nl/ . Accessed May 21 2018

2. Turnbull C, Rahman N (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9:321–345

3. Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34(13):1460–1468

4. Claus EB, Risch NJ, Thompson D (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131(6):961–972

5. NABON (2017) Breast Cancer, Dutch Guideline [Internet]. http://www.oncoline.nl/borstkanker . Accessed May 25 2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome;European Journal of Cancer;2024-11

2. Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers;Breast Cancer;2024-07-17

3. Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer;Breast Cancer Research and Treatment;2024-06-15

4. Detection of TP53 gene mutation in blood of breast cancer patients based on circulating tumor DNA and its application in prognosis;Cellular and Molecular Biology;2023-11-15

5. Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort;Cancers;2023-06-29